Cancer Lawsuit

Actos Warning : Tobacco smoking and occupational exposure have been the two major factors related to BC risk; however, not all smokers develop BC and not all cases of BC occurred in smokers or patients with chemical exposure. It has been proposed that there could be factors other than environmental that could affect the incidence on urothelial tumors. In fact, as for many other cancers, molecular researchers are trying to establish genetic alterations linked to carcinogenesis that could justify genetic predisposition.An important research has been conducted in patients with BC in relation to smoking and chemical exposure , trying to identify those patients with higher sus­ceptibility of being affected by environmental carcinogens. Aromatic amines were established carcinogens for urothelium.

More information on Actos Warning

They could be inactivated by acetylation pathway, and it has been postulated that those patients with slow acetylation capability were more susceptible to BC than those that are rapid acetylators. NAT-1 and NAT-2 are N-acetyltransferase genes located on the short arm of human chromosome 8 and they are involved in amines inactivation. Reduction in NAT-2 activity has been suggested as mechanism for BC predisposition among patients exposed to environmental carcinogens such as aromatic amines.A number of SNPs have been reported in NAT-2 coding exon, as well as over 35 NAT-2 haplotypes have been identified (Hein 2006). Several of these haplotypes corresponded to NAT-2 slow acetylator phenotype and NAT-2 slow acetylation genotype has been related to higher risk of BC.

Information from other sources on Actos Warning

The Spanish Bladder Cancer Study is a hospital-based case-control study on BC conducted in five different areas in Spain that included 1150 cases and 1149 controls. They evaluated in this great population the association of several polymorphisms in NAT and GST genes with BC risk and their interaction with cigarette smoking. In addition, they reported a metaanalysis of 29 studies of NAT-2 and BC including 5096 cases and 6519 controls. They demonstrated that NAT-2 slow acetylators had a 40% increase in BC risk compared to rapid/intermediate acetylators with an OR of 1.4 (95% CI, 1.2-1.7). They could also demonstrate a significant multiplication interaction between NAT-2 slow acetylation genotype and cigarette smoking, that is, NAT-2 slow acetylators were especially susceptible to the adverse effects of ciga­rette smoking on BC risk. On the other hand, the metaanalysis performed corrobo­rated their own data, being the summary on relative risk for NAT-2 slow acetylators compared to rapid/intermediate acetylators of 1.4 (Garcia-Closas et al. 2005).Other SNPs in different genes have been studied. Nucleotide excision repair (NER) pathway is a complex mechanism for repairing DNA damage and subse­quently for preventing carcinogenesis. NER pathway included several genes, and different SNPs on those genes have been related to an increase in BC risk. Twenty- two SNPs on seven NER genes were evaluated in 1150 cases and 1149 controls included in The Spanish Bladder Cancer Study. Four of these 22 SNPs in NER genes could be significantly related to a small increase in BC risk and interestingly it could be demonstrated as a stronger association between BC and polymorphism in ERCC2 gene (ERCC2 R156R) for never-smokers compared with ever-smokers (Garcia-Closas et al. 2006).

Other study including 696 patients with BC and 629 controls evaluated the asso­ciation with BC risk of a comprehensive panel of 44 SNPs in genes of NER path­way and genes involved in cell cycle control. They concluded that patients with higher numbers of variants in NER genes rather than single polymorphism are at increased risk for BC (Wu et al. 2006).

Our use of the term or terms Actos Warning is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Warning visit our site often.

http://www.seedol.com

Actos Warning : Exposure to a number of chemicals has been associated with the development of bladder cancer. These include ani­line dyes and other members of the aromatic amine family. People who work in occupations where exposure to these chemicals is common include textile workers, dye workers, rubber workers, painters, and even hairdressers. Please see Table 1-1 for a list of occupations associated with an in­creased risk of developing bladder cancer.

Smoking is the most common cause of bladder cancer today. It increases your risk of developing bladder cancer 2- to 4-fold compared with people who don’t smoke. The risk of bladder cancer increases with the frequency and duration of smoking. For example, someone who smokes one pack a day for 20 years has a higher risk of bladder cancer than someone who smokes a few cigarettes on week­ends. When you stop smoking you can slowly decrease the risk of bladder cancer, over the course of 20-30 years. If you currently smoke, it would be best to stop smoking

More information on Actos Warning

Chronic inflammation of your bladder may also place you at an increased risk of developing a specific type of bladder cancer called squamous cell carcinoma. Inflammation occurs when one has an untreated urinary tract infection, bladder stones, an indwelling bladder catheter, or an infec­tion with a parasite called Schistosoma haematobium. Para­plegics or quadriplegics who require a catheter to drain their bladders and those who live in areas where S. haema­tobium is common are at greatest risk.

Information from other sources on Actos Warning

Saridon (phenacetin) and Cytoxan (cyclophosphamide) are two other substances that can increase your risk of bladder cancer. Phenacetin is a pain medicine that is no longer used that was previously shown to be associated with bladder cancer. Cytoxan is a drug used for chemotherapy that has been associated with bladder cancer. This may sound puzzling as you wonder, “how does one drug used to treat cancer cause another cancer?” Cytoxan itself is not the problem. Most medications are broken down by our bodies into components before being eliminated in our stool or urine. One of the byproducts of cyclophosphamide, called acrolein, can irritate the wall of your bladder, causing a lot of blood in your urine. Over time, this can increase the risk of developing bladder cancer.

A history of radiation therapy for a pelvic cancer may increase your risk of bladder cancer. Radiation has a role in the treatment of prostate, cervical, and ovarian cancers. Although the radiation is focused on the involved organ, the bladder and other surrounding structures also absorb radiation that sometimes damages the urothelium and leads to cancer.

Our use of the term or terms Actos Warning is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Warning visit our site often.

http://www.seedol.com

Actos Warning : Some scientists believe this may help improve your outcome from treatment. If you smoke a pipe or cigar, you may also have an increased risk for developing bladder cancer, but cigarettes are the main culprit behind bladder cancer today.

Chronic inflammation of your bladder may also place you at an increased risk of developing a specific type of bladder cancer called squamous cell carcinoma. Inflammation occurs when one has an untreated urinary tract infection, bladder stones, an indwelling bladder catheter, or an infection with a parasite called Schistosoma haematobium. Paraplegics or quadriplegics who require a catheter to drain their bladders and those who live in areas where S. haematobium is common are at greatest risk.

More information on Actos Warning

Saridon (phenacetin) and Cytoxan (cyclophosphamide) are two other substances that can increase your risk of bladder cancer. Phenacetin is a pain medicine that is no longer used that was previously shown to be associated with bladder cancer. Cytoxan is a drug used for chemotherapy that has been associated with bladder cancer. This may sound puzzling as you wonder, “how does one drug used to treat cancer cause another cancer?” Cytoxan itself is not the problem. Most medications are broken down by our bodies into components before being eliminated in our stool or urine. One of the byproducts of cyclophosphamide, called acrolein, can irritate the wall of your bladder, causing a lot of blood in your urine. Over time, this can increase the risk of developing bladder cancer.

Information from other sources on Actos Warning

A history of radiation therapy for a pelvic cancer may increase your risk of bladder cancer. Radiation has a role in the treatment of prostate, cervical, and ovarian cancers. Although the radiation is focused on the involved organ, the bladder and other surrounding structures also absorb radiation that sometimes damages the urothelium and leads to cancer.

Our use of the term or terms Actos Warning is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Warning visit our site often.

http://www.seedol.com

Actos Warning : Much attention has been paid to the influence of diet on cancer risk and treatment. Thus far, some scientists have suggested that vegetables, fresh fruits, and some fermented milk products appear to decrease one’s risk of developing bladder cancer. A few foods thought to increase the risk of developing bladder cancer are foods rich in animal fat, diose containing a lot of cholesterol, fried foods, and processed meat with various additives. We are not sure of the exact influence of diet on bladder cancer at this point in time. Scientists around the world are working on uncovering potential links between diet and bladder cancer.

ARE THERE VARIOUS TYPES OF BLADDER CANCER?

As with other cancers that affect different body parts, there are multiple types of bladder cancer. To better understand them, let’s separate bladder cancer into two different groups: primary tumors that originate in the bladder and secondary tumors that spread to the bladder from other places.

More information on Actos Warning

Primary bladder cancers form within the bladder. Over 90 percent of primary bladder cancers in the United States are of the urothelial or transitional subtype. These form along the inner lining of the bladder. The second most common type of primary bladder cancer in the United States is squamous cell carcinoma, making up approximately 5 percent of all cancers diagnosed. These are often diagnosed in individuals whose bladder has been chronically irritated by an infection, stones, or an indwelling catheter. The third most common subtype of bladder cancer in the United States is adenocarcinoma, accounting for approximately 2 percent of all diagnosed cases. These typically form near the dome of the bladder. There are other types of primary bladder cancer, but these are very rare. If necessary, your urologist will speak to you about these rare types.

Information from other sources on Actos Warning

Secondary cancers form somewhere else in the body and spread to the bladder. Other tumors can get to the bladder by using the bloodstream, your lymphatic system, or directly from an organ close to the bladder. Other cancers that spread to the bladder, in order of decreasing frequency, are melanoma, colon cancer, prostate cancer, lung cancer, and breast cancer.

Now that we’ve discussed some of the basics concerning bladder cancer, let’s examine how you should go about choosing a medical team to treat your cancer.

Our use of the term or terms Actos Warning is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Warning visit our site often.

http://www.seedol.com